Related Experiment Videos
[Pigmented exanthema after spironolactone allergy in progressive systemic scleroderma]
Deutsche Medizinische Wochenschrift (1946)
|December 16, 1983
Summary
A patient with scleroderma experienced hyperpigmentation, which worsened after a spironolactone-induced allergic reaction. This reaction led to persistent, localized skin pigmentation due to melanin deposition and melanophages.
Area of Science:
- Dermatology
- Pharmacology
- Pathology
Background:
- Progressive systemic scleroderma can cause skin hyperpigmentation.
- Spironolactone is a medication sometimes used to manage scleroderma symptoms.
Observation:
- A 37-year-old male patient with scleroderma developed generalized hyperpigmentation.
- Histological examination revealed melanin granules in the epidermis and corneocytes.
- An allergic rash occurred after spironolactone administration, followed by slate-grey spots.
Findings:
- The drug rash exacerbated existing hyperpigmentation, causing significant pigment deposition in the upper dermis.
- Melanophages were observed, indicating the body's attempt to remove melanin granules.
- The allergic reaction triggered persistent, circumscribed, and spotty skin pigmentation.
Implications:
- Drug-induced allergic reactions can significantly alter and worsen pre-existing skin conditions like hyperpigmentation.
- Understanding the interaction between systemic diseases, medications, and pigmentary changes is crucial for patient management.
- This case highlights the complex interplay between autoimmune disease, drug hypersensitivity, and resulting dermatological manifestations.